Archives: Speakers

Diran Adelakun is the Manager of Clinical Monitoring Services at Clinlogix. He is responsible for supporting the company’s global strategies as it relates to study monitoring design and implementation. He has been working in the clinical stratosphere for 15+ years over a vast array of therapeutic experience.

Mark Koziel became President and CEO of Allinial Global in August 2020 after 14 years with the American Institute of Certified Public Accountants (AICPA). In addition to leading a team of twenty-seven staff members, he is responsible for strategic planning, financial performance, and the association’s overall growth and success.

From the beginning of his career at a large local accounting firm in Buffalo, New York, to his tenure as Executive Vice President of Firm Services at the AICPA, Mark has been a leader and consistent advocate for CPA firms. Well known and highly regarded within the profession, he has appeared among the top 10 of Accounting Today’s Top 100 Most Influential People in Accounting and been named to the International Accounting Bulletin’s Global Accounting Power 50 List.

Theo Christie is a Business Development Manager (Commercial) for the NIHR Clinical Research Network (CRN). He facilitates discussions between the life sciences industry and the Clinical Research Network and provides advice to companies on how they are able to access government-funded support to ensure clinical trials are set up efficiently and recruit to time and target in the UK.

Shannon Childs consults with clients on strategic initiatives and partners closely with our Schlesinger Clinical Research team on regulated healthcare research to facilitate real-world insight and evidence, marketing claims, label comprehensions, parity, and superiority testing.

With over 25 years of experience, Shannon has worked with large pharma, medical device, and biotech organizations generating quality information to inform strategic decision making. Before joining Schlesinger Group in August of 2020, she spent most of her career at Ipsos Healthcare (and several years prior at the insights firm PG Research). Shannon is a critical thinker, focused on problem-solving, and is seasoned in leading teams that deliver above industry satisfaction scores.

Shannon has a Bachelor of Science Degree in Marketing from Clemson University and a Masters in Business Administration from Meredith College.

Shannon lives in North Carolina with her husband Doug, has 3 children, 3 beagles, and volunteers in her spare time as a cheer coach.

Iman is a strong clinical and regulatory expert with 15+ years’ experience in managing pharmaceutical and device studies, including domestic US trials, and larger multinational global studies. She works closely with the Regulatory department in the development and submission of IDE, IND, 510(k), and PMA applications for orthopedic devices.

As Sr. Clinical Director, Iman leverages her expert knowledge of FDA regulations and ICH/GCP guidelines to design pre- and post-market clinical studies in a manner that helps drive clinical and regulatory compliance and ensures superior data quality. She assists clients with the identification and qualification of orthopedic sites that help ensure their trial’s success. She has assisted with the development of clinical protocols that incorporate strategic regulatory, statistical and reimbursement objectives so that our clients can use each clinical trial to collect data required by all stakeholders. She also advises clients on the use of innovative statistical analyses that can help reduce a study’s sample size and/or allow for an early success/failure determination. Iman also provides strategic guidance to clients on how to maintain inspection readiness at research sites, and how to prepare for a BIMO inspection.

Prior to joining MCRA, Iman worked under the functional service provider arm of a large CRO (Syneos, previously known as Inventiv), where she conducted risk based monitoring, and was responsible for overseeing all aspects of Phase I/II study implementation for a major pharmaceutical company.  Prior to working at Inventiv, she led several DoD funded trials at a medical device start up and served as a safety reporting consultant at NIAID (NIH). She also spent 5+ years managing Phase I-III HIV prevention trials funded by the Gates Foundation in the US, UK, Europe and Africa.

Iman graduated from Stanford University with a Bachelor of Science in Human Biology before gaining her Master of Science in Biotechnology from Georgetown University.